MENU
+Compare
BVS
Stock ticker: NASDAQ
AS OF
Jan 13, 04:59 PM (EDT)
Price
$7.72
Change
-$0.03 (-0.39%)
Capitalization
519.07M

BVS Bioventus Forecast, Technical & Fundamental Analysis

Bioventus Inc is a medical technology company... Show more

BVS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for BVS with price predictions
Jan 12, 2026

BVS sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for BVS moved above the 200-day moving average on December 24, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 06, 2026. You may want to consider a long position or call options on BVS as a result. In of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BVS just turned positive on January 08, 2026. Looking at past instances where BVS's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

BVS moved above its 50-day moving average on January 05, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BVS advanced for three days, in of 266 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 177 cases where BVS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BVS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BVS broke above its upper Bollinger Band on January 08, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BVS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.125) is normal, around the industry mean (63.131). P/E Ratio (48.438) is within average values for comparable stocks, (38.425). BVS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.669). BVS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (0.934) is also within normal values, averaging (39.675).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BVS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
BVS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

BVS is expected to report earnings to rise 36.13% to 20 cents per share on March 17

Bioventus BVS Stock Earnings Reports
Q4'25
Est.
$0.20
Q3'25
Beat
by $0.04
Q2'25
Est.
$0.21
Q1'25
Beat
by $0.04
Q4'24
Beat
by $0.07
The last earnings report on November 04 showed earnings per share of 15 cents, beating the estimate of 10 cents. With 53.50K shares outstanding, the current market capitalization sits at 519.07M.
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
4721 Emperor Boulevard
Phone
+1 919 474-6700
Employees
970
Web
https://www.bioventus.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GMAPX30.820.08
+0.26%
Goldman Sachs Small Cap Eq Insghts P
GABUX4.890.01
+0.20%
Gabelli Utilities AAA
VSQCX15.000.03
+0.20%
Invesco MSCI World SRI Index C
PRERX27.040.03
+0.11%
Principal Real Estate Securities R3
SPRAX28.140.02
+0.07%
PGIM Quant Solutions Mid-Cap Val A

BVS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BVS has been loosely correlated with LIVN. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if BVS jumps, then LIVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BVS
1D Price
Change %
BVS100%
-3.49%
LIVN - BVS
51%
Loosely correlated
-3.15%
TCMD - BVS
42%
Loosely correlated
-1.22%
OFIX - BVS
42%
Loosely correlated
-3.36%
IART - BVS
41%
Loosely correlated
-3.17%
AVNS - BVS
39%
Loosely correlated
-3.08%
More

Groups containing BVS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BVS
1D Price
Change %
BVS100%
-3.49%
Health Services
category (412 stocks)
6%
Poorly correlated
+1.08%
Medical/Nursing Services
category (220 stocks)
5%
Poorly correlated
+1.38%